Commerce Bank’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
VPM
VCM
RCM
EAM
Commerce Bank's SRPT Position: Q1 2026 in Review
Commerce Bank increased its Sarepta Therapeutics (SRPT) stake by 0.66% in Q1 2026, buying an estimated $3.12K and bringing the position to 24,494 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #914.
Commerce Bank first reported a position in SRPT in Q1 2020 and has held it in 18 quarters since. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.
- Commerce Bank held 24,494 shares of Sarepta Therapeutics worth $533K as of Q1 2026.
- Commerce Bank bought 161 Sarepta Therapeutics shares in Q1 2026, an estimated $3.12K.
- Sarepta Therapeutics made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #914 holding.
- Commerce Bank first reported a position in Sarepta Therapeutics in Q1 2020 and has held it in 18 quarters since.
- 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.
Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.